MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-12-19+125,000→ 125,000 totalExercise: $5.36From: 2024-12-19Exp: 2034-02-20→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]On February 20, 2024, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was regulatory submission of AD-004 for Alzheimer's disease (US or EU). The performance criteria for this milestone was met with the acceptance of the MAA filing by the EMA, resulting in vesting of the option as to 125,000 shares.